76 related articles for article (PubMed ID: 37367045)
21. Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment.
Ward AV; Anderson SM; Sartorius CA
J Mammary Gland Biol Neoplasia; 2021 Dec; 26(4):399-417. PubMed ID: 34914014
[TBL] [Abstract][Full Text] [Related]
22. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments.
Gómez-Cebrián N; Domingo-Ortí I; Poveda JL; Vicent MJ; Puchades-Carrasco L; Pineda-Lucena A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572770
[TBL] [Abstract][Full Text] [Related]
23. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
[TBL] [Abstract][Full Text] [Related]
24. Lipid metabolism and cancer.
Bian X; Liu R; Meng Y; Xing D; Xu D; Lu Z
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601415
[TBL] [Abstract][Full Text] [Related]
25. siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line.
Savukaitytė A; Gudoitytė G; Bartnykaitė A; Ugenskienė R; Juozaitytė E
Cancer Manag Res; 2021; 13():1123-1133. PubMed ID: 33574709
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic translation initiation factors as promising targets in cancer therapy.
Hao P; Yu J; Ward R; Liu Y; Hao Q; An S; Xu T
Cell Commun Signal; 2020 Nov; 18(1):175. PubMed ID: 33148274
[TBL] [Abstract][Full Text] [Related]
27. Beyond Chemotherapies: Recent Strategies in Breast Cancer Treatment.
Foulon A; Theret P; Rodat-Despoix L; Kischel P
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32947780
[TBL] [Abstract][Full Text] [Related]
28. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study.
Heer E; Harper A; Escandor N; Sung H; McCormack V; Fidler-Benaoudia MM
Lancet Glob Health; 2020 Aug; 8(8):e1027-e1037. PubMed ID: 32710860
[TBL] [Abstract][Full Text] [Related]
29. Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway.
Wu Y; Yan B; Xu W; Guo L; Wang Z; Li G; Hou N; Zhang J; Ling R
Int J Biol Sci; 2020; 16(4):583-597. PubMed ID: 32025207
[TBL] [Abstract][Full Text] [Related]
30. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
Schlaepfer IR; Joshi M
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31900483
[TBL] [Abstract][Full Text] [Related]
31. Untargeted Metabolomics to Go beyond the Canonical Effect of Acetylsalicylic Acid.
Di Minno A; Porro B; Turnu L; Manega CM; Eligini S; Barbieri S; Chiesa M; Poggio P; Squellerio I; Anesi A; Fiorelli S; Caruso D; Veglia F; Cavalca V; Tremoli E
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31878351
[TBL] [Abstract][Full Text] [Related]
32. Reprogramming of fatty acid metabolism in cancer.
Koundouros N; Poulogiannis G
Br J Cancer; 2020 Jan; 122(1):4-22. PubMed ID: 31819192
[TBL] [Abstract][Full Text] [Related]
33. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Cardoso F; Kyriakides S; Ohno S; Penault-Llorca F; Poortmans P; Rubio IT; Zackrisson S; Senkus E;
Ann Oncol; 2019 Aug; 30(8):1194-1220. PubMed ID: 31161190
[No Abstract] [Full Text] [Related]
34. AMP-activated protein kinase: the current landscape for drug development.
Steinberg GR; Carling D
Nat Rev Drug Discov; 2019 Jul; 18(7):527-551. PubMed ID: 30867601
[TBL] [Abstract][Full Text] [Related]
35. A novel mechanism for the anticancer activity of aspirin and salicylates.
Bashir AIJ; Kankipati CS; Jones S; Newman RM; Safrany ST; Perry CJ; Nicholl ID
Int J Oncol; 2019 Apr; 54(4):1256-1270. PubMed ID: 30720135
[TBL] [Abstract][Full Text] [Related]
36. Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines.
Koobotse M; Holly J; Perks C
Oncotarget; 2018 Sep; 9(71):33562-33576. PubMed ID: 30323899
[TBL] [Abstract][Full Text] [Related]
37. The carnitine system and cancer metabolic plasticity.
Melone MAB; Valentino A; Margarucci S; Galderisi U; Giordano A; Peluso G
Cell Death Dis; 2018 Feb; 9(2):228. PubMed ID: 29445084
[TBL] [Abstract][Full Text] [Related]
38. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.
Pinto JA; Rolfo C; Raez LE; Prado A; Araujo JM; Bravo L; Fajardo W; Morante ZD; Aguilar A; Neciosup SP; Mas LA; Bretel D; Balko JM; Gomez HL
Sci Rep; 2017 May; 7(1):1526. PubMed ID: 28484222
[TBL] [Abstract][Full Text] [Related]
39. Fatty acid metabolism in breast cancer subtypes.
Monaco ME
Oncotarget; 2017 Apr; 8(17):29487-29500. PubMed ID: 28412757
[TBL] [Abstract][Full Text] [Related]
40. Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.
Henry WS; Laszewski T; Tsang T; Beca F; Beck AH; McAllister SS; Toker A
Cancer Res; 2017 Feb; 77(3):790-801. PubMed ID: 27940576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
